163 related articles for article (PubMed ID: 25190114)
1. Liver resection for metastatic disease after y90 radioembolization: a case series with long-term follow-up.
Henry LR; Hostetter RB; Ressler B; Bowser I; Yan M; Vaghefi H; Abad J; Gulec S; Schwarz RE
Ann Surg Oncol; 2015 Feb; 22(2):467-74. PubMed ID: 25190114
[TBL] [Abstract][Full Text] [Related]
2. Hepatectomy After Yttrium-90 (Y90) Radioembolization-Induced Liver Fibrosis.
Maker AV; August C; Maker VK; Weisenberg E
J Gastrointest Surg; 2016 Apr; 20(4):869-70. PubMed ID: 26847353
[TBL] [Abstract][Full Text] [Related]
3. Survival after repeat hepatic resection for recurrent colorectal metastases.
Chiappa A; Zbar AP; Biella F; Staudacher C
Hepatogastroenterology; 1999; 46(26):1065-70. PubMed ID: 10370668
[TBL] [Abstract][Full Text] [Related]
4. (90) Y radiation lobectomy: Outcomes following surgical resection in patients with hepatic tumors and small future liver remnant volumes.
Lewandowski RJ; Donahue L; Chokechanachaisakul A; Kulik L; Mouli S; Caicedo J; Abecassis M; Fryer J; Salem R; Baker T
J Surg Oncol; 2016 Jul; 114(1):99-105. PubMed ID: 27103352
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Y-90 Radioembolization After Prior Major Hepatic Resection.
Zimmermann M; Schulze-Hagen M; Liebl M; Pedersoli F; Goerg F; Ulmer TF; Heinzel A; Isfort P; Kuhl C; Bruners P
Cardiovasc Intervent Radiol; 2017 Aug; 40(8):1206-1212. PubMed ID: 28357572
[TBL] [Abstract][Full Text] [Related]
6. Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity.
Padia SA; Kwan SW; Roudsari B; Monsky WL; Coveler A; Harris WP
J Vasc Interv Radiol; 2014 Jul; 25(7):1067-73. PubMed ID: 24837982
[TBL] [Abstract][Full Text] [Related]
7. Yttrium-90 radioembolization of renal cell carcinoma metastatic to the liver.
Abdelmaksoud MH; Louie JD; Hwang GL; Kothary N; Minor DR; Sze DY
J Vasc Interv Radiol; 2012 Mar; 23(3):323-30.e1. PubMed ID: 22277275
[TBL] [Abstract][Full Text] [Related]
8. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases.
Jakobs TF; Hoffmann RT; Dehm K; Trumm C; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Helmberger TK; Reiser MF
J Vasc Interv Radiol; 2008 Aug; 19(8):1187-95. PubMed ID: 18656012
[TBL] [Abstract][Full Text] [Related]
9. Impact of prior hepatectomy on the safety and efficacy of radioembolization with yttrium-90 microspheres for patients with unresectable liver tumors.
Bester L; Feitelson S; Milner B; Chua TC; Morris DL
Am J Clin Oncol; 2014 Oct; 37(5):454-60. PubMed ID: 23388564
[TBL] [Abstract][Full Text] [Related]
10. Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience.
Tohme S; Sukato D; Chen HW; Amesur N; Zajko AB; Humar A; Geller DA; Marsh JW; Tsung A
J Vasc Interv Radiol; 2013 Nov; 24(11):1632-8. PubMed ID: 24160821
[TBL] [Abstract][Full Text] [Related]
11. Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease.
Cardona K; Donataccio D; Kingham TP; Allen PJ; DeMatteo RP; Fong Y; Jarnagin WR; Cercek A; Kemeny NE; D'Angelica MI
Ann Surg Oncol; 2014 Mar; 21(3):815-21. PubMed ID: 24242675
[TBL] [Abstract][Full Text] [Related]
12. The extent of resection influences outcome following hepatectomy for colorectal liver metastases.
Stewart GD; O'Súilleabháin CB; Madhavan KK; Wigmore SJ; Parks RW; Garden OJ
Eur J Surg Oncol; 2004 May; 30(4):370-6. PubMed ID: 15063889
[TBL] [Abstract][Full Text] [Related]
13. Radioembolization with Yttrium-90 microspheres (SIRT) in pancreatic cancer patients with liver metastases: efficacy, safety and prognostic factors.
Michl M; Haug AR; Jakobs TF; Paprottka P; Hoffmann RT; Bartenstein P; Boeck S; Haas M; Laubender RP; Heinemann V
Oncology; 2014; 86(1):24-32. PubMed ID: 24401529
[TBL] [Abstract][Full Text] [Related]
14. Hepatic resection with reconstruction of the inferior vena cava or hepatic venous confluence for metastatic liver tumor from colorectal cancer.
Aoki T; Sugawara Y; Imamura H; Seyama Y; Minagawa M; Hasegawa K; Kokudo N; Makuuchi M
J Am Coll Surg; 2004 Mar; 198(3):366-72. PubMed ID: 14992737
[TBL] [Abstract][Full Text] [Related]
15. Synchronous resection of primary and liver metastases for neuroendocrine tumors.
Gaujoux S; Gonen M; Tang L; Klimstra D; Brennan MF; D'Angelica M; Dematteo R; Allen PJ; Jarnagin W; Fong Y
Ann Surg Oncol; 2012 Dec; 19(13):4270-7. PubMed ID: 22752376
[TBL] [Abstract][Full Text] [Related]
16. Yttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: a large single-center experience of 40 patients.
Saxena A; Kapoor J; Meteling B; Morris DL; Bester L
Ann Surg Oncol; 2014 Apr; 21(4):1296-303. PubMed ID: 24337647
[TBL] [Abstract][Full Text] [Related]
17. Two-stage resection for bilobar colorectal liver metastases: R0 resection is the key.
Tsim N; Healey AJ; Frampton AE; Habib NA; Bansi DS; Wasan H; Cleator SJ; Stebbing J; Lowdell CP; Jackson JE; Tait P; Jiao LR
Ann Surg Oncol; 2011 Jul; 18(7):1939-46. PubMed ID: 21298352
[TBL] [Abstract][Full Text] [Related]
18. Is hepatectomy safe following Yttrium-90 therapy? A multi-institutional international experience.
Melstrom LG; Eng OS; Raoof M; Singh G; Fong Y; Latorre K; Choi GH; Salem R; Bentrem DJ; Lewandowski R; Makris E; Poultsides G; Dhar VK; Chadalavada S; Shah SA; Johnson AC; Sekhar A; Kies D; Maithel SK; Rocha F; Alseidi A; Hagendoorn J; Borel Rinkes IHM; Fisher AV; Ronnekleiv-Kelly S; Weber SM; Winslow ER; Abbott DE
HPB (Oxford); 2019 Nov; 21(11):1520-1526. PubMed ID: 31005493
[TBL] [Abstract][Full Text] [Related]
19. Serious hepatic complications of selective internal radiation therapy with yttrium-90 microsphere radioembolization for unresectable liver tumors.
Kuo JC; Tazbirkova A; Allen R; Kosmider S; Gibbs P; Yip D
Asia Pac J Clin Oncol; 2014 Sep; 10(3):266-72. PubMed ID: 25135200
[TBL] [Abstract][Full Text] [Related]
20. Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma.
Iñarrairaegui M; Pardo F; Bilbao JI; Rotellar F; Benito A; D'Avola D; Herrero JI; Rodriguez M; Martí P; Zozaya G; Dominguez I; Quiroga J; Sangro B
Eur J Surg Oncol; 2012 Jul; 38(7):594-601. PubMed ID: 22440743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
